Thank you.
Let me start with the first issue you raised related to personal information. As I stated in my opening comments to the committee, we proactively sought out the Privacy Commissioner's input into this legislation to protect the privacy information of individuals. I will be happy to share with the committee the letter we received from the Privacy Commissioner saying she's happy with the legislation and the provisions in this legislation that support privacy. I'll give that to you.
I would also like to say that the proposed amendment that was introduced in the Senate related to privacy issues basically goes beyond what we're asking for. The proposed amendment that was introduced by the senator said to collect more unnecessary information that we need to make an informed decision on an unsafe product. So they said to collect personal information, like the individual's age, address, social insurance number, date of birth--information that we do not need to make an informed decision on an unsafe product.
The issue here is the product. So that's a concern we're struggling with, in that the Privacy Commissioner is satisfied with what we've done here, but the proposed amendment goes beyond what we need in Health Canada to make an informed decision on an unsafe product.
On the acceptable level of cadmium, I'm going to refer that to the officials to respond.
Thank you.